Loading clinical trials...

COMPLETEDNCT01272076

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

The objective of this study is to compare Cirrus HD-OCT automated measurements of the illumination area under the retinal pigment epithelium (RPE) to expert manual measurements of areas of hypofluores...

Lead sponsor: Carl Zeiss Meditec, Inc.•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269 · Geographic Atrophy Secondary to Age-related Macular Degeneration

RECRUITING

High Resolution Retinal Imaging

NCT01866371 · Stargardts, Retinitis Pigmentosa, and more

RECRUITINGPhase 1/2

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

NCT07392255 · Geographic Atrophy Secondary to Age-related Macular Degeneration

RECRUITINGNA

Strategies for Improving Linkage-to-Care After Eye Disease Screening

NCT06943599 · Age Related Macular Degeneration, Diabetic Retinopathy, and more

RECRUITINGPhase 1

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

NCT07230834 · Geographic Atrophy (GA)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 20, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment85

Start dateJan 2011

Last updatedJan 20, 2014

Condition

Locations shown

East Bay Retina Consultants, Inc.

Oakland, California

TLC Eyecare and Laser Centers

Jackson, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 20, 2014Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions